What are the trends in remote patient monitoring?

This blog post has been written by the person who has mapped the remote patient monitoring market in a clean and beautiful presentation

The remote patient monitoring (RPM) market is experiencing unprecedented transformation as AI-driven analytics, cellular-enabled devices, and smartphone biomarkers reshape how healthcare providers deliver care outside traditional settings.

From established chronic disease management platforms to emerging ambient sensors and voice-analysis diagnostics, RPM technologies are evolving rapidly while navigating new reimbursement models and regulatory frameworks. The sector's projected 25% CAGR through 2026 reflects both technological maturation and healthcare's shift toward value-based care delivery.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

What are the long-established trends in remote patient monitoring that continue to shape the market today?

Four foundational trends established between 2020-2023 continue dominating RPM adoption: continuous glucose monitoring, implantable cardiac devices, virtual ward programs, and EHR integration with telehealth platforms.

Continuous glucose monitoring represents the most successful RPM deployment, with 12.6 million users in 2023 across Dexcom and Abbott FreeStyle Libre systems. These devices deliver proven glycemic control improvements while significantly reducing hypoglycemic and hyperglycemic events. The CGM market's maturity provides a blueprint for other chronic disease monitoring applications.

Implantable cardiac devices like CardioMEMS and HeartLogic systems enable continuous monitoring of heart failure patients through wireless data transmission. These platforms detect early signs of cardiac decompensation, leading to proactive interventions that reduce hospital readmissions and mortality rates. The clinical validation of these systems has established cardiac monitoring as RPM's most reimbursed specialty.

Virtual ward and hospital-at-home programs coordinate remote monitoring with home nursing services and teleconsultations. These programs achieve up to 40% reduction in readmissions while providing scalable alternatives to traditional hospital beds. The integration of vitals monitoring with care team coordination has proven essential for managing complex patients outside acute care settings.

Value-based care models increasingly incentivize RPM adoption as providers seek to meet quality metrics and population health goals. Advanced Primary Care Management codes and Accountable Care Organization contracts now incorporate RPM data into reimbursement calculations, creating sustainable financial models for remote monitoring programs.

What are the most exciting emerging trends in remote patient monitoring right now?

AI-driven predictive analytics, cellular-enabled plug-and-play devices, virtual clinics with intelligent triage, multimodal ambient sensors, and smartphone-based biomarkers represent the five most compelling emerging trends reshaping RPM delivery in 2025.

AI predictive analytics platforms use machine learning models to analyze continuous vitals and behavioral patterns, flagging potential deterioration before clinical symptoms appear. Companies like Biofourmis and physIQ deploy algorithms that identify arrhythmias, heart failure decompensation, and sepsis risk from wearable sensor data. These systems reduce false positives while enabling earlier interventions that prevent emergency department visits.

Cellular-enabled RPM devices transmit data over 4G/5G networks without requiring patient smartphones or Wi-Fi connections. This technology eliminates digital literacy barriers and connectivity issues that previously limited RPM adoption among elderly and rural populations. HealthSnap and Tenovi lead this segment by offering turnkey cellular monitoring solutions that work immediately upon patient receipt.

Virtual clinics combine RPM data collection with end-to-end care coordination workflows, tele-visits, and patient advocacy services. Platforms like Solace and CoachCare integrate monitoring devices with care team management, medication adherence tracking, and lifestyle coaching. These comprehensive solutions address the fragmentation that has historically limited RPM's clinical impact.

Multimodal ambient sensors capture health data without requiring wearable devices. Contactless radar systems monitor respiratory patterns and sleep quality, while under-mattress sensors track movement and vital signs during rest. LiDAR technology can detect falls and gait changes, providing continuous safety monitoring for aging populations.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

If you want updated data about this market, you can download our latest market pitch deck here

What new technologies or approaches in remote patient monitoring are still very early but could become significant soon?

Four breakthrough technologies in research and early clinical trials could fundamentally expand RPM capabilities: ambient room sensors using radar and LiDAR, voice-analysis diagnostics for neurological conditions, next-generation implantable biosensors, and closed-loop digital therapeutics integration.

Ambient room sensors eliminate wearability requirements entirely by using radar, LiDAR, and computer vision to monitor patients continuously. These systems track gait patterns, detect falls, and measure respiratory rates from wall-mounted or ceiling-installed devices. Neteera's radar-based systems and similar technologies are undergoing clinical pilots for elderly monitoring and post-acute care applications.

Voice-analysis diagnostics leverage AI models to detect depression, cognitive decline, Parkinson's disease, and respiratory conditions through speech biomarkers. Sonde Health and similar companies analyze vocal patterns, speech rhythm, and linguistic changes that precede clinical symptom onset. Early trials show promise for screening and monitoring neurological conditions through simple phone-based assessments.

Next-generation implantable biosensors will enable continuous molecular monitoring of glucose, lactate, inflammatory markers, and drug levels through wireless-powered microchips. These devices promise real-time biochemical data without finger sticks or laboratory visits. While still in prototype development, successful deployment could revolutionize chronic disease management and medication optimization.

Digital therapeutics integration creates closed-loop systems where RPM data automatically triggers therapeutic interventions. Examples include insulin dosing adjustments based on continuous glucose data, neurostimulation parameter changes responding to seizure detection, and medication reminders triggered by adherence monitoring. Regulatory pathways for these autonomous systems are still developing but could enable truly personalized medicine delivery.

Which trends in remote patient monitoring seemed promising but have faded or lost momentum recently?

Three previously hyped RPM trends have significantly lost momentum: standalone telehealth video visits, consumer fitness trackers for clinical monitoring, and blockchain-based health data exchange platforms.

Standalone telehealth video visits peaked during the COVID-19 public health emergency but declined rapidly as reimbursement policies tightened and providers returned to in-person care preferences. The transactional nature of video-only consultations provided limited clinical depth compared to integrated RPM approaches that combine continuous data with virtual interactions. Patient engagement and physician satisfaction with video-only visits decreased substantially once emergency policies ended.

Consumer fitness trackers like basic Fitbit or Apple Watch models proved inadequate for clinical RPM applications due to data reliability issues and poor EHR integration capabilities. Healthcare providers require medical-grade accuracy and seamless data flow into clinical workflows, features that consumer devices cannot reliably provide. The failure of consumer wearables in clinical settings has driven focus toward purpose-built medical devices with FDA clearance and clinical validation.

Blockchain technologies for health data exchange generated significant hype but failed to achieve meaningful real-world deployment due to complexity, high implementation costs, and unclear return on investment. Privacy regulations, technical integration challenges, and lack of standardized protocols prevented blockchain from solving interoperability problems as promised. Most healthcare organizations have moved toward cloud-based APIs and traditional data exchange methods instead.

Which trends have generated a lot of hype in the industry but may not have lasting impact?

Big-data health marketplaces, direct-to-consumer RPM subscriptions, and multi-vendor wellness ecosystems represent three heavily hyped trends that face significant sustainability challenges despite continued industry attention.

Which trends are now gaining real momentum and traction in the market?

Three regulatory and business model changes are driving unprecedented RPM market momentum: flexible CPT coding implementation, FQHC/RHC billing inclusion, and strategic AI platform partnerships between device manufacturers and software companies.

The AMA's removal of the 16-day minimum requirement for RPM services, effective 2026, fundamentally expands patient eligibility and clinical use cases. New 2-15 day RPM supply codes enable short-term monitoring for post-surgical recovery, medication titration, and acute episode management. This flexibility aligns reimbursement with diverse clinical needs rather than arbitrary duration requirements, potentially doubling the addressable patient population.

CMS finalization of CPT codes 99453/99454/99457/99458 for Federally Qualified Health Centers and Rural Health Clinics removes previous billing restrictions that limited RPM access in underserved areas. These changes enable rural and community health centers to implement RPM programs with sustainable reimbursement, addressing healthcare access gaps that traditional models couldn't reach. Early implementations show 30%+ improvement in chronic disease management metrics among previously underserved populations.

Major device manufacturers including Philips and Medtronic are acquiring or partnering with AI analytics platforms like Biofourmis and Huma to create integrated hardware-software solutions. These partnerships combine established device reliability with advanced data analytics capabilities, offering healthcare providers complete RPM platforms rather than fragmented point solutions. The consolidation trend creates competitive advantages for companies offering end-to-end monitoring and care coordination.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

If you want to grasp this market fast, you can download our latest market pitch deck here

Which startups are actively innovating around these different types of trends in remote patient monitoring?

Leading RPM innovation spans six categories with distinct startup ecosystems: AI predictive analytics, cellular connectivity, virtual care coordination, continuous vitals monitoring, smartphone biomarkers, and ambient sensing technologies.

What key patient pain points and healthcare provider challenges are these trends aiming to address?

RPM innovations target five critical healthcare delivery challenges: hospital readmission reduction, healthcare access equity, patient engagement improvement, clinical workflow optimization, and data security with interoperability.

Hospital readmissions represent the most expensive preventable healthcare cost, with 30-day readmission rates reaching 15-20% for heart failure and COPD patients. AI-driven early warning systems analyze continuous vitals to predict decompensation 24-72 hours before clinical symptoms appear, enabling proactive interventions that prevent costly acute episodes. Successful RPM programs achieve 25-40% readmission reduction through timely medication adjustments and lifestyle interventions.

Healthcare access inequities affect rural populations and elderly patients who face transportation barriers, digital literacy challenges, and broadband connectivity limitations. Cellular-enabled RPM devices and audio-only telehealth consultations eliminate these barriers by providing medical-grade monitoring without requiring smartphones or internet connections. FQHC and RHC billing inclusion enables underserved communities to access RPM services previously available only in urban, well-connected areas.

Patient engagement remains the largest obstacle to successful chronic disease management, with medication adherence rates below 50% for many conditions. Behavioral nudges through smartphone apps, personalized health dashboards, and gamification elements increase patient participation in self-monitoring activities. Advanced platforms integrate social determinants of health data to customize engagement strategies for individual patient circumstances and preferences.

Clinical workflow burden prevents many providers from adopting RPM despite potential benefits. AI-powered triage systems automatically prioritize patient alerts based on clinical significance, reducing false alarms that cause alert fatigue. Care coordination platforms streamline data review by presenting actionable insights rather than raw measurements, enabling providers to manage larger patient populations efficiently.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

How is the competitive landscape evolving as a result of these trends?

The RPM competitive landscape is consolidating through vertical integration, strategic partnerships, and niche specialization as established medical device companies acquire software platforms while startups focus on specific clinical domains.

Major consolidation involves device original equipment manufacturers like Philips, Medtronic, and Abbott acquiring AI analytics and care coordination platforms to offer complete end-to-end solutions. These acquisitions eliminate integration challenges between hardware and software components while providing healthcare systems with single-vendor accountability for RPM program outcomes. The trend toward platform consolidation reduces market fragmentation but may limit innovation from smaller specialized companies.

Strategic partnerships between payors and RPM companies align financial incentives with clinical outcomes through shared-risk arrangements. UPMC and Labcorp's co-investment in Percipio Health exemplifies how health systems and laboratory companies collaborate to develop RPM solutions that directly support value-based care contracts. These partnerships create competitive moats through exclusive access to patient populations and claims data.

Vertical integration extends beyond technology to include home nursing agencies, durable medical equipment suppliers, and care coordination services. Virtual ward providers partner with visiting nurse organizations to provide comprehensive hospital-at-home services that combine remote monitoring with in-person clinical support. This integration creates higher barriers to entry but enables more comprehensive patient care than technology-only solutions.

Niche specialization allows smaller companies to compete by focusing on specific clinical domains like musculoskeletal rehabilitation (Limber Health), maternal health monitoring (Babyscripts), or mental health tracking (Sonde Health). These specialized platforms develop deep clinical expertise and regulatory pathways that generalist RPM companies cannot easily replicate, creating defensible market positions despite limited scope.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

What regulatory or reimbursement changes are driving or hindering these trends?

Four major regulatory developments are accelerating RPM adoption: Medicare CPT code expansion, rural health clinic billing inclusion, value-based care integration, and AMA duration requirement elimination, while fraud oversight concerns create implementation guardrails.

Medicare's continued support for CPT codes 99453/99454/99457/99458 through 2025 and beyond provides reimbursement stability that enables healthcare providers to invest in RPM infrastructure. The inclusion of Rural Health Clinics and Federally Qualified Health Centers in CPT billing eligibility expands RPM access to underserved populations previously excluded from reimbursement programs. These changes address healthcare equity concerns while creating new market opportunities for RPM vendors.

The AMA's 2026 implementation of flexible duration requirements removes the arbitrary 16-day minimum that previously limited RPM applications to chronic disease management. New 2-15 day supply codes enable post-surgical monitoring, medication titration oversight, and short-term acute episode management with appropriate reimbursement. Lower interactive-time thresholds reduce administrative burden on clinical staff while maintaining quality oversight requirements.

Value-based care integration through Advanced Primary Care Management codes (G0556-G0558) incorporates RPM data into population health reimbursement calculations. These codes reward providers for achieving clinical outcomes rather than service volume, aligning RPM investments with long-term patient health improvements. Successful RPM programs contribute directly to shared-savings calculations in Medicare Shared Savings Program and other value-based contracts.

Fraud oversight initiatives by the Office of Inspector General and Peterson Center highlight concerns about RPM overutilization and inappropriate billing practices. New guidance emphasizes clinical necessity documentation, outcome measurement requirements, and duration limits to prevent abuse while preserving legitimate clinical applications. These oversight measures create compliance costs but also establish industry credibility by eliminating fraudulent actors.

What are the expected developments in remote patient monitoring by 2026?

By 2026, the US RPM market will reach $18 billion driven by flexible CPT implementation, AI analytics maturation, cellular device proliferation, and integration into value-based care frameworks across major health systems.

Market size expansion reflects both increased patient eligibility through revised CPT codes and higher per-patient value from comprehensive monitoring platforms. The elimination of 16-day minimum requirements enables RPM deployment for short-term clinical needs, potentially doubling the addressable patient population. Revenue growth will shift from device supply toward AI analytics and care coordination services as platforms mature beyond basic data collection.

Technology integration will center on AI-driven predictive analytics becoming standard features rather than premium add-ons. Machine learning models for early deterioration detection will achieve clinical validation across multiple chronic conditions, reducing false positive rates while improving sensitivity for genuine clinical emergencies. Edge computing deployment will enable real-time analysis without cloud dependence, reducing latency for critical alerts.

Geographic expansion will accelerate through cellular-enabled devices that eliminate connectivity barriers in rural and underserved areas. FQHC and RHC billing inclusion will drive RPM adoption in community health centers, tribal health programs, and frontier medical practices previously excluded from reimbursement programs. International markets will adopt US-validated RPM models through local partnerships and regulatory adaptations.

Platform consolidation will result in fewer but more comprehensive RPM solutions as device manufacturers acquire software companies to offer end-to-end monitoring and care coordination. Healthcare systems will prefer single-vendor accountability for RPM outcomes rather than managing multiple point solutions, driving market concentration among integrated platform providers.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

How might the remote patient monitoring market evolve over the next five years?

The RPM market will evolve from monitoring-focused tools into comprehensive care delivery platforms fully integrated with value-based care models, featuring edge-AI deployment, global expansion, and convergence with digital therapeutics for closed-loop patient management by 2030.

Full integration into value-based care frameworks will make RPM data essential for shared-savings programs, risk-based contracts, and population health management. Advanced Primary Care Management codes and Medicare Advantage Special Needs Plans will require RPM components for chronic disease management, creating mandatory rather than optional adoption for many provider organizations. Success metrics will shift from utilization measures to clinical outcomes and total cost of care reduction.

Regulatory expansion will extend Remote Therapeutic Monitoring (RTM) and behavioral monitoring codes to mental health, rehabilitation, and cognitive assessment applications. Digital therapeutics integration will enable closed-loop systems where RPM data automatically triggers therapy adjustments for insulin dosing, neurostimulation parameters, and medication optimization. FDA approval pathways for autonomous therapeutic systems will mature, enabling truly personalized medicine delivery.

Edge-AI deployment will reduce cloud dependence and data transmission costs while enabling real-time analysis for critical patient conditions. On-device processing will provide immediate alerts for cardiac events, falls, and respiratory distress without relying on internet connectivity. This technology advancement will make RPM viable for emergency response and acute care applications beyond current chronic disease focus.

Global market expansion will accelerate through low-bandwidth, smartphone-based RPM solutions adapted for emerging markets with limited healthcare infrastructure. Successful US platforms will establish international partnerships to deploy validated monitoring approaches in Europe, Asia, and developing regions. Regulatory harmonization efforts will reduce approval barriers for cross-border RPM technology deployment.

Convergence with digital therapeutics will create integrated platforms where monitoring data drives automated therapeutic interventions. Examples include continuous glucose monitoring controlling insulin pump delivery, seizure detection adjusting neurostimulation parameters, and depression monitoring triggering cognitive behavioral therapy modules. These closed-loop systems will represent the ultimate evolution from passive monitoring to active therapeutic management.

Conclusion

Sources

1. Medixine - Remote Monitoring Surges to 76.7 Million Patients Worldwide
2. Doccla - What is Remote Patient Monitoring
3. Tenovi - Remote Patient Monitoring Telehealth History and Future
4. HealthArc - 8 Remote Patient Monitoring RPM Trends
5. MediTech Insights - Remote Patient Monitoring Market
6. HealthSnap - AI in Remote Patient Monitoring Top 4 Use Cases
7. Support Save - Future Trends in Remote Patient Monitoring Solutions
8. Quick Market Pitch - Remote Patient Monitoring Funding
9. PMC - Remote Patient Monitoring Research
10. YouTube - Remote Patient Monitoring Analysis
11. Prevounce - AMA Approves Substantial Expansion of RPM Codes
12. Business Insider - Healthcare Experts Say Telehealth's Future Could Be Remote Monitoring
13. Med Device Online - Cutting Through the Remote Patient Monitoring Hype
14. Interest Journals - Emerging Trends in Telemedicine and Remote Patient Monitoring
15. Synsormed - AMA RPM CPT Rule Change for 2026
16. Open Loop Health - 2025 Remote Patient Monitoring CPT Codes Quick Guide
17. Thorough Care - Remote Patient Monitoring 2025 CPT Codes and Reimbursements
18. LinkedIn - Remote Patient Monitoring HealthTech Post
19. CMS - Telehealth Remote Patient Monitoring Guidelines
20. Smart Meter RPM - 2025 RPM CPT Summary for Providers
21. LinkedIn - AMA Panel Changes Major Reporting Requirement
22. Medify Health - 2025 RPM Regulations Update
23. Hogan Lovells - AI Health Law Policy Remote Patient Monitoring